PSC Marker Panels for Residual Pluripotent Cell Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for detecting pluripotent stem cells (PSCs) are inadequate for identifying small numbers of residual undifferentiated PSCs in differentiated cell populations due to marker genes also being expressed in differentiated cells, leading to challenges in quality control and potential tumorigenicity.
Innovation Solution
Utilization of a subset of marker genes uniquely expressed in PSCs, with at least 90% sequence identity to SEQ ID NOs: 1-28, for detecting and quantifying PSCs through techniques like dd-PCR, PCR, and microarray analysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional marker genes are used for detecting PSCs, then detection capability is provided, but false positive results occur due to marker expression in differentiated cells
Solution Approach 1:
The patent segments the detection approach by using a panel of multiple marker genes (including NANOG, OCT4, SOX2, and others) rather than relying on a single marker. This segmentation allows for more specific identification of residual PSCs by detecting the combined expression pattern across multiple genes, reducing false positives from differentiated cells that may express individual markers.
Solution Approach 2:
The patent changes the detection parameters by establishing specific expression thresholds and using quantitative real-time PCR to measure marker gene expression levels. By setting cutoff values based on differentiated cell controls and requiring expression above these thresholds, the method achieves higher specificity for detecting residual PSCs while maintaining reliability.
2Measurement precision
If sensitive detection methods are used to identify small numbers of residual PSCs, then detection sensitivity is improved, but false positive results increase due to marker expression in differentiated cells
Solution Approach 1:
The patent uses an intermediary approach by employing a panel of marker genes as mediators between the target (residual PSCs) and the detection system. The combination of multiple markers acts as an intermediary filter that distinguishes true PSC signals from background noise in differentiated cells, enabling sensitive detection while maintaining reliability through the collective specificity of the marker panel.
Solution Approach 2:
The patent changes detection parameters by establishing expression thresholds and using quantitative measurement to distinguish true positive signals from false positives. By setting cutoff values based on differentiated cell controls and requiring expression above these thresholds, the method achieves high sensitivity while maintaining reliability.
3Reliability
If comprehensive marker detection is performed to ensure quality control, then detection reliability is improved, but detection complexity and time increase
Solution Approach 1:
The patent applies universality by designing a detection method that can be applied across different PSC-derived cell types and differentiation protocols. The panel of marker genes serves multiple functions: identifying residual PSCs, verifying differentiation completeness, and ensuring product safety. This multi-functional approach achieves comprehensive quality control without requiring separate assays for different cell types.
Solution Approach 2:
The patent employs self-service by using the marker gene expression patterns themselves to provide the detection signal. The endogenous expression of markers like NANOG, OCT4, and SOX2 in PSCs naturally provides the detection target, eliminating the need for exogenous labeling or complex staining procedures. The cells essentially detect themselves through their own marker expression.
Data Source
AI summary
The present disclosure provides markers specific for pluripotent stem cells. In particular, the present disclosure relates to nucleic acid and polypeptide markers that are selectively expressed by pluripotent stem cells; and to methods for detecting the presence and/or absence of one or a plurality of pluripotent stem cells, by detecting such markers.